Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GHSR | Q92847 | 1/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.43 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.41 |
| ▸ | STS | P08842 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 4/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | HTT | P42858 | 3/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.40 |
| ▸ | TYR | P14679 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7787192 | 0.82 | S1PR3 (0.47) | MEN1KMT2AMAPTHTTTSHR | |
| SCHEMBL8953038 | 0.82 | MEN1 (0.43) | MEN1KMT2AMAPTHTTTSHR | |
| SCHEMBL7779141 | 0.82 | S1PR3 (0.47) | MEN1KMT2AMAPTHTTTSHR | |
| SCHEMBL7779134 | 0.82 | S1PR3 (0.47) | MEN1KMT2AMAPTHTTTSHR | |
| SCHEMBL8954900 | 0.82 | S1PR3 (0.47) | MEN1KMT2AMAPTHTTTSHR | |
| SCHEMBL7787208 | 0.82 | S1PR3 (0.47) | MEN1KMT2AMAPTHTTTSHR | |
| SCHEMBL339909 | 0.82 | S1PR3 (0.47) | MEN1KMT2AMAPTHTTTSHR | |
| SCHEMBL16563961 | 0.82 | S1PR3 (0.47) | MEN1KMT2AMAPTHTTTSHR | |
| SCHEMBL7787174 | 0.82 | S1PR3 (0.47) | MEN1KMT2AMAPTHTTTSHR | |
| SCHEMBL11148043 | 0.82 | MEN1 (0.46) | GHSRTRPV1MEN1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230081679-A1 | SURFACTANT VESICLES FOR VACCINE FORMULATION, TARGETED DRUG DELIVERY, AND TRANSFECTION | UNIV MARYLAND (US) | 2023-03-16 | — | — | US | claimed |
| US-20260001783-A1 | ENHANCED FOAM REMOVAL OF TOTAL SUSPENDED SOLIDS AND MULTIPLY CHARGED CATIONS FROM AQUEOUS OR AQUEOUS/OIL MIXED PHASE VIA INCREASED VISCOELASTICITY | ECOLAB USA INC (US) | 2026-01-01 | — | — | US | disclosed |
| US-12428318-B2 | Enhanced foam removal of total suspended solids and multiply charged cations from aqueous or aqueous/oil mixed phase via increased viscoelasticity | ECOLAB USA INC. (US) | 2025-09-30 | — | — | US | disclosed |
| US-12291748-B2 | Acridinium ester-containing compounds and methods of using the same for chemiluminescence-based one-color sequencing | MGI HOLDINGS CO., LIMITED (CN) | 2025-05-06 | — | — | US | disclosed |
| CN-119236105-A | Multifunctional anti-tumor nano-drug delivery system based on copper death and preparation method and application thereof | 中南大学 | 2025-01-03 | — | — | CN | disclosed |
| US-20240286929-A1 | ENHANCED FOAM REMOVAL OF TOTAL SUSPENDED SOLIDS AND MULTIPLY CHARGED CATIONS FROM AQUEOUS OR AQUEOUS/OIL MIXED PHASE VIA INCREASED VISCOELASTICITY | ECOLAB USA INC. | 2024-08-29 | — | — | US | disclosed |
| US-11987505-B2 | Enhanced foam removal of total suspended solids and multiply charged cations from aqueous or aqueous/oil mixed phase via increased viscoelasticity | ECOLAB USA INC. (US) | 2024-05-21 | — | — | US | disclosed |
| US-11929257-B2 | Etching solution and method for aluminum nitride | VERSUM MATERIALS US, LLC (US) | 2024-03-12 | — | — | US | disclosed |
| CN-117618580-A | Medicine-carrying mesoporous silica and preparation method thereof | 东沃同泰(凤城)生物工程有限公司 | 2024-03-01 | — | — | CN | disclosed |
| CN-117380276-A | Preparation method of functional covalent organic framework nanocomposite capable of removing active oxygen | 南京大学 | 2024-01-12 | — | — | CN | disclosed |
| US-20230339781-A1 | ENHANCED FOAM FRACTIONATION OF OIL PHASE FROM AQUEOUS/OIL MIXED PHASE VIA INCREASED VISCOELASTICITY | ECOLAB USA INC. | 2023-10-26 | — | — | US | disclosed |
| CN-116421618-B | Preparation method of Se@NADH and application of Se@NADH in spinal cord injury treatment | 暨南大学 | 2023-09-29 | — | — | CN | disclosed |
| CN-116712566-A | Nanometer system for resisting coronavirus infection and preparation method and application thereof | 中国科学院上海硅酸盐研究所 | 2023-09-08 | — | — | CN | disclosed |
| US-11718540-B2 | Enhanced foam fractionation of oil phase from aqueous/oil mixed phase via increased viscoelasticity | ECOLAB USA INC. (US) | 2023-08-08 | — | — | US | disclosed |
| CN-116421618-A | Preparation method of Se@NADH and application of Se@NADH in spinal cord injury treatment | 暨南大学 | 2023-07-14 | — | — | CN | disclosed |
| US-20230081679-A1 | SURFACTANT VESICLES FOR VACCINE FORMULATION, TARGETED DRUG DELIVERY, AND TRANSFECTION | UNIV MARYLAND (US) | 2023-03-16 | — | — | US | disclosed |
| US-20220367199-A1 | ETCHING SOLUTION AND METHOD FOR ALUMINUM NITRIDE | VERSUM MATERIALS US, LLC (US) | 2022-11-17 | — | — | US | disclosed |
| EP-4010484-A1 | ACRIDINIUM ESTER-CONTAINING COMPOUNDS AND METHODS OF USING THE SAME FOR CHEMILUMINESCENCE-BASED ONE-COLOR SEQUENCING | BGI Shenzhen Co., Limited (CN) | 2022-06-15 | — | — | EP | disclosed |
| CN-114245830-A | Acridinium ester-containing compound and method for using same for chemiluminescence-based monochromatic sequencing | 深圳华大基因科技有限公司 | 2022-03-25 | — | — | CN | disclosed |
| CN-112957345-B | Light-operated drug release degradable temperature-sensitive mesoporous silicon nanoparticle system | 济南国科医工科技发展有限公司 | 2022-03-08 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260001783-A1 | ENHANCED FOAM REMOVAL OF TOTAL SUSPENDED SOLIDS AND MULTIPLY CHARGED CATIONS FROM AQUEOUS OR AQUEOUS/OIL MIXED PHASE VIA INCREASED VISCOELASTICITY | FLOT1, FLNA, MUC1 | GHSR 3744/4885HDAC3 2553/4885HDAC1 1897/4885 |
| US-12291748-B2 | Acridinium ester-containing compounds and methods of using the same for chemiluminescence-based one-color sequencing | ACR, CES2, PDE6C | GHSR 1101/4885HDAC3 3592/4885HDAC1 4146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.